WEKO3
アイテム
{"_buckets": {"deposit": "56aca15e-9414-46c8-adfe-01d0aa4b53ba"}, "_deposit": {"created_by": 1, "id": "65682", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "65682"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00065682", "sets": ["29"]}, "author_link": ["647024", "647025", "647020", "647023", "647021", "647026", "647027", "647008", "647015", "647009", "647017", "647014", "647029", "647028", "647019", "647016", "647018", "647010", "647013", "647012", "647011", "647022"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2015-06-10", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Objectives: Overexpression of metabotropic glutamate1 receptor (mGlu1) is found in brain and various cancers (1). Recently, we constructed the first mGlu1 oncoprotein-based PET platform with mGlu1-specific radioprobe 18F-FITM (2). However, 18F-FITM displayed high uptake of radioactivity both in brain and melanoma, which increased the risk of radiation-induced brain injury, then hampered its clinical application. In this study, using FITM as a lead compound, we developed a novel PET probe 4-iodo-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-11C-methyl- benzamide (11C-IITM) and explored its potential for melanoma imaging.\nMethods: 11C-IITM was synthesized by N-11C-methylation of the desmethyl precursor with 11C-CH3OTf. In vitro binding affinity for mGlu1 was assayed. PET imaging and biodistribution were performed in the mice bearing B16F10 melanoma with rich mGlu1 expression.\nResults: 11C-IITM was obtained with radiochemical yields of 20 5% (n \u003e 10 based on 11C-CO2, EOS), radiochemical purity of \u003e97%, and specific activity of 65–160 GBq/mol. PET showed high accumulation of radioactivity in target tumor (4.0 % ID/g) and very low uptake in non-target brain (0.9 % ID/g) in B16F10-bearing mice at 75 min after 11C-IITM injection. Ex vivo biodistribution confirmed the PET images and indicated better uptake ratio of tumor to brain in 11C-IITM (8.03 ± 0.46), compared with 18F-FITM (0.58 ± 0.05) at 90 min. In addition, the ratios of radioactivity for 11C-IITM in the tumor compared to blood, skin, and muscle at 90 min were 5-10. Treatment with an mGlu1 selective ligand significantly reduced radioactive uptake in the tumor. \nConclusions: 11C-IITM is a useful PET tracer for mGlu1 imaging in melanoma. This radioprobe can be further developed by 124I and 131I labeling for long-duration PET scan and radiotherapeutic usage.", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "SNMMI 2015 Annual Meeting ", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Xie, Lin"}], "nameIdentifiers": [{"nameIdentifier": "647008", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Fujinaga, Masayuki"}], "nameIdentifiers": [{"nameIdentifier": "647009", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamasaki, Tomoteru"}], "nameIdentifiers": [{"nameIdentifier": "647010", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yui, Joji"}], "nameIdentifiers": [{"nameIdentifier": "647011", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shimoda, Yoko"}], "nameIdentifiers": [{"nameIdentifier": "647012", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hatori, Akiko"}], "nameIdentifiers": [{"nameIdentifier": "647013", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kumata, Katsushi"}], "nameIdentifiers": [{"nameIdentifier": "647014", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Zhang, Yiding"}], "nameIdentifiers": [{"nameIdentifier": "647015", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nengaki, Nobuki"}], "nameIdentifiers": [{"nameIdentifier": "647016", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kawamura, Kazunori"}], "nameIdentifiers": [{"nameIdentifier": "647017", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Zhang, Ming-Rong"}], "nameIdentifiers": [{"nameIdentifier": "647018", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "謝 琳", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "647019", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "藤永 雅之", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "647020", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "山崎 友照", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "647021", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "由井 譲二", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "647022", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "下田 陽子", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "647023", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "羽鳥 晶子", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "647024", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "熊田 勝志", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "647025", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "張 一鼎", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "647026", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "念垣 信樹", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "647027", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "河村 和紀", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "647028", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "張 明栄", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "647029", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "Developing 4-iodo-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N- 11C-methylbenzamide for imaging of metabotropic glutamate 1 receptor in melanoma ", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Developing 4-iodo-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N- 11C-methylbenzamide for imaging of metabotropic glutamate 1 receptor in melanoma "}]}, "item_type_id": "10005", "owner": "1", "path": ["29"], "permalink_uri": "https://repo.qst.go.jp/records/65682", "pubdate": {"attribute_name": "公開日", "attribute_value": "2015-06-17"}, "publish_date": "2015-06-17", "publish_status": "0", "recid": "65682", "relation": {}, "relation_version_is_last": true, "title": ["Developing 4-iodo-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N- 11C-methylbenzamide for imaging of metabotropic glutamate 1 receptor in melanoma "], "weko_shared_id": -1}
Developing 4-iodo-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N- 11C-methylbenzamide for imaging of metabotropic glutamate 1 receptor in melanoma
https://repo.qst.go.jp/records/65682
https://repo.qst.go.jp/records/656822f671253-0fee-4667-8dd7-c5293f5e7dea
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2015-06-17 | |||||
タイトル | ||||||
タイトル | Developing 4-iodo-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N- 11C-methylbenzamide for imaging of metabotropic glutamate 1 receptor in melanoma | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Xie, Lin
× Xie, Lin× Fujinaga, Masayuki× Yamasaki, Tomoteru× Yui, Joji× Shimoda, Yoko× Hatori, Akiko× Kumata, Katsushi× Zhang, Yiding× Nengaki, Nobuki× Kawamura, Kazunori× Zhang, Ming-Rong× 謝 琳× 藤永 雅之× 山崎 友照× 由井 譲二× 下田 陽子× 羽鳥 晶子× 熊田 勝志× 張 一鼎× 念垣 信樹× 河村 和紀× 張 明栄 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Objectives: Overexpression of metabotropic glutamate1 receptor (mGlu1) is found in brain and various cancers (1). Recently, we constructed the first mGlu1 oncoprotein-based PET platform with mGlu1-specific radioprobe 18F-FITM (2). However, 18F-FITM displayed high uptake of radioactivity both in brain and melanoma, which increased the risk of radiation-induced brain injury, then hampered its clinical application. In this study, using FITM as a lead compound, we developed a novel PET probe 4-iodo-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-11C-methyl- benzamide (11C-IITM) and explored its potential for melanoma imaging. Methods: 11C-IITM was synthesized by N-11C-methylation of the desmethyl precursor with 11C-CH3OTf. In vitro binding affinity for mGlu1 was assayed. PET imaging and biodistribution were performed in the mice bearing B16F10 melanoma with rich mGlu1 expression. Results: 11C-IITM was obtained with radiochemical yields of 20 5% (n > 10 based on 11C-CO2, EOS), radiochemical purity of >97%, and specific activity of 65–160 GBq/mol. PET showed high accumulation of radioactivity in target tumor (4.0 % ID/g) and very low uptake in non-target brain (0.9 % ID/g) in B16F10-bearing mice at 75 min after 11C-IITM injection. Ex vivo biodistribution confirmed the PET images and indicated better uptake ratio of tumor to brain in 11C-IITM (8.03 ± 0.46), compared with 18F-FITM (0.58 ± 0.05) at 90 min. In addition, the ratios of radioactivity for 11C-IITM in the tumor compared to blood, skin, and muscle at 90 min were 5-10. Treatment with an mGlu1 selective ligand significantly reduced radioactive uptake in the tumor. Conclusions: 11C-IITM is a useful PET tracer for mGlu1 imaging in melanoma. This radioprobe can be further developed by 124I and 131I labeling for long-duration PET scan and radiotherapeutic usage. |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | SNMMI 2015 Annual Meeting | |||||
発表年月日 | ||||||
日付 | 2015-06-10 | |||||
日付タイプ | Issued |